Home
May 19
Saturday



"No one can predict the future But now we can prepare"

 
 

619.702.1404

Bio-Matrix strives to
improve the quality of life
by introducing the latest
in medical technology
to the public.

Latest Press

Regen BioPharma Inc., Secures $20,000,000
04/30/2012

SOURCE: Bio-Matrix Scientific Group Inc. April 30, 2012 08:30 ET Bio-Matrix Scientific G [ ... ]


PDF Print E-mail

Welcome to Bio-Matrix

Bio-Matrix Scientific Group, Inc. (Pink: BMSN) is a biotechnology company focused on the development of regenerative medicine therapies and tools. The Company is specifically focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to lung, heart, circulatory system and other internal organs.


 

Through Its wholly owned subsidiary, Regen BioPharma, it is the Company’s goal to develop translational medicine platforms for the rapid commercialization of stem cell therapies. The Company is looking to use these translational medicine platforms to advance intellectual property licensed from entities, institutions and universities that show promise towards fulfilling the Company’s goal of increased quality of life.


 

Areas of Interest:

Cord and Peripheral Blood Banking

Stem Cell Research Alliances / Partnering

Cell Culturing Projects

Diabetes Related Research

Diabetes

Chronic Obstructive Pulmonary Disease (COPD)

Heart Related illness

Circulatory issues


 

Bio-Matrix Scientific Group is poised to work with both domestic and international entities.

 


FACILITIES FOR USE BY HOSPITALS, RESEARCH FIRMS AND PHYSICIANS

Health care professionals that want to offer the most up to date patient care.


INVESTOR RELATIONS


Bio-Matrix is a pioneer in stem cell biotechnology. Learn more about the company and industry.

Home